Elmiron Vision Side Effects May Cause Pigmentary Maculopathy

Harvey Kirk

By Harvey Kirk
Posted April 13, 2020


The product liability lawyers at Saiontz & Kirk, P.A. are now investigating potential lawsuits for users of the interstitial cytisis/bladder pain syndrome drug Elmiron, which may have caused a type of retina damage and vision loss known as pigmentary maculopathy.

Contact Our Elmiron Lawyers For VISION LOSS SIDE EFFECTS

  • Have You Experienced Problems
    Following an MRI with Contrast?
  • Step 1 of 2

*By submitting, you authorize Saiontz & Kirk, P.A. to send text messages to the numbers provided, including information & offers, possibly using automated technology. Message/data rates apply. Consent is not a condition for acceptance of services.
Saiontz & Kirk, PA, Attorneys & Lawyers, Baltimore, MD

The medication has been sold for decades without proper warnings about the importance of monitoring for Elmiron vision side effects, which may initially surface with symptoms like:

  • Progressive vision loss or deterioration of the eyes;
  • Blurry vision or distorted vision;
  • Difficulty reading;
  • Prolonged dark adaption or problems seeing at night;
  • Loss of detailed vision;
  • Darkening vision;

Over the past few years, a series of case reports and studies have been published that highlight the growing evidence about a link between Elmiron and eye problems involving an atypical maculopathy that may worsen over time and result in permanent retinal injury.

As a result of the drug manufacturers failure to adequately warn about the potential Elmiron side effects on vision, many ophthalmologists were unaware of the drug toxicity on the retina and users were often misdiagnosed and kept on the drug, potentially worsening the eye damage.

Elmiron Vision Loss Problems Have Often Been Misdiagnosed Due to Drug Makers’ Failure to Warn

While this condition is now increasingly referred to as Elmiron maculopathy or pigmentary maculopathy in prior years the vision loss may have been diagnosed under other names or as other retinal disease, including:

  • Age-Related Macular Degeneration (AMD)
  • Macular Retinopathy
  • Pattern Distrophy
  • Retinal Macular Dystrophy
  • Macular Toxicity
  • Retinal Pigmentary Changes
  • Other Maculopathy

It appears that Janssen Pharmaceuticals knew or should have known about the Elmiron vision risks, yet placed it’s desire for profits before the safety of consumers by withholding information from users and the medical community.

UPDATE: In June 2020, the drug makers updated the warning label, providing information for the first time about the potential link between Elmiron and eye damage. However, this information comes too late for thousands of long-term users who have already been left with irreversible retina damage and pigmentary changes that may have been avoided or less serious if earlier information had been disclosed.

Elmiron Vision Loss Lawyers

Contact Saiontz & Kirk, P.A. today to review a potential claim for yourself, a friend or a loved one. All Elmiron vision loss lawsuits are being pursued by our law firm under a contingency fee agreement, which means that there are never any out-of-pocket costs to hire our lawyers and we only receive an attorney fee or expenses if a settlement or recovery is obtained for your vision side effects.


No Comments • Add Your Comments

Add Your Comments

  • Have Your Comments Reviewed by a Lawyer

    Provide contact information below and additional private comments if you want an attorney to contact you to review a potential case.

    The information below will not be published to this page.

  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.